Company Overview:
Beam Therapeutics is committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
We are seeking an energetic scientist with broad experience in the development of analytical methods for mRNA, gRNA, pDNA, and mAb platforms. The successful candidate will have deep understanding of analytical control strategy, CMC, product lifecycles, analytical regulatory guidances for mRNA, gRNA, pDNA, and/or mAb platforms. This position will primarily focus on analytical method development for one or more of the above molecule types. Some CMC and outsourcing management may also be involved.
The ideal candidate will have experience in development and execution of analytical methods for mRNA, gRNA, pDNA, and mAb platforms under quality-by-design concepts, experience working collaboratively with cross-functional internal research and CMC teams (process development, regulatory, quality control, quality assurance), and management of external testing/manufacturing labs. This position will require a strong working knowledge of analytical ICH/USP guidelines.
Primary Responsibilities:
Qualifications: